Original Article

Development of Chronic Inflammatory Arthropathy Resembling Rheumatoid Arthritis in Interleukin 1 Receptor Antagonist–deficient Mice

Correspondence to: Yoichiro Iwakura, Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Tel:81-3-5449-5536 Fax:81-3-5449-5430 E-mail:iwakura{at}ims.u-tokyo.ac.jp.

Interleukin (IL)-1 is a proinflammatory cytokine that plays important roles in inflammation, host defense, and the neuro-immuno-endocrine network. IL-1 receptor antagonist (ra) is an endogenous inhibitor of IL-1 and is supposed to regulate IL-1 activity. However, its pathophysiological roles in a body remain largely unknown. To elucidate the roles of IL-1ra, IL-1ra–deficient mice were produced by gene targeting, and pathology was analyzed on different genetic backgrounds. We found that all of the mice on a BALB/cA background, but not those on a C57BL/6J background, spontaneously developed chronic inflammatory polyarthropathy. Histopathology showed marked synovial and periarticular inflammation, with articular erosion caused by invasion of granulation tissues closely resembling that of rheumatoid arthritis in humans. Moreover, elevated levels of antibodies against immunoglobulins, type II collagen, and double-stranded DNA were detected in these mice, suggesting development of autoimmunity. Proinflammatory cytokines such as IL-1ß, IL-6, and tumor necrosis factor were overexpressed in the joints, indicating regulatory roles of IL-1ra in the cytokine network. We thus show that IL-1ra gene deficiency causes autoimmunity and joint-specific inflammation and suggest that IL-1ra is important in maintaining homeostasis of the immune system. Possible involvement of IL-1ra gene deficiency in RA will be discussed.

Key Words: IL-1 receptor antagonist, rheumatoid arthritis, autoimmunity, cytokine, animal model

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Wakasa-Morimoto, C., Toyosaki-Maeda, T., Matsutani, T., Yoshida, R., Nakamura-Kikuoka, S., Maeda-Tanimura, M., Yoshitomi, H., Hirota, K., Hashimoto, M., Masaki, H., Fujii, Y., Sakata, T., Tsuruta, Y., Suzuki, R., Sakaguchi, N., Sakaguchi, S. (2008). Arthritis and pneumonitis produced by the same T cell clones from mice with spontaneous autoimmune arthritis. Int Immunol 0: dxn091v1-dxn091 [Abstract] [Full Text]  
• Brinster, C., Shevach, E. M. (2008). Costimulatory effects of IL-1 on the expansion/differentiation of CD4+CD25+Foxp3+ and CD4+CD25+Foxp3- T cells. J. Leukoc. Biol. 84: 480-487 [Abstract] [Full Text]  
• Abe, K., Wechs, S., Kalaydjiev, S., Franz, T. J., Busch, D. H., Fuchs, H., Soewarto, D., Behrendt, H., Wagner, S., Jakob, T., Hrabe de Angelis, M. (2008). Novel lymphocyte-independent mechanisms to initiate inflammatory arthritis via bone marrow-derived cells of Ali18 mutant mice. Rheumatology (Oxford) 47: 292-300 [Abstract] [Full Text]  
• Andoh, T., Kishi, H., Motoki, K., Nakanishi, K., Kuraishi, Y., Muraguchi, A. (2008). Protective Effect of IL-18 on Kainate- and IL-1{beta}-Induced Cerebellar Ataxia in Mice. J. Immunol. 180: 2322-2328 [Abstract] [Full Text]  
• Zwerina, J., Redlich, K., Polzer, K., Joosten, L., Kronke, G., Distler, J., Hess, A., Pundt, N., Pap, T., Hoffmann, O., Gasser, J., Scheinecker, C., Smolen, J. S., van den Berg, W., Schett, G. (2007). TNF-induced structural joint damage is mediated by IL-1. Proc. Natl. Acad. Sci. USA 104: 11742-11747 [Abstract] [Full Text]  
• Itoh, Y., Hayashi, H., Miyazawa, K., Kojima, S., Akahoshi, T., Onozaki, K. (2007). 17beta-Estradiol Induces IL-1{alpha} Gene Expression in Rheumatoid Fibroblast-Like Synovial Cells through Estrogen Receptor {alpha} (ER{alpha}) and Augmentation of Transcriptional Activity of Sp1 by Dissociating Histone Deacetylase 2 from ER{alpha}. J. Immunol. 178: 3059-3066 [Abstract] [Full Text]  
• Venteclef, N., Delerive, P. (2007). Interleukin-1 Receptor Antagonist Induction as an Additional Mechanism for Liver Receptor Homolog-1 to Negatively Regulate the Hepatic Acute Phase Response. J. Biol. Chem. 282: 4393-4399 [Abstract] [Full Text]  
• Krelin, Y., Voronov, E., Dotan, S., Elkabets, M., Reich, E., Fogel, M., Huszar, M., Iwakura, Y., Segal, S., Dinarello, C. A., Apte, R. N. (2007). Interleukin-1{beta}-Driven Inflammation Promotes the Development and Invasiveness of Chemical Carcinogen-Induced Tumors. Cancer Res. 67: 1062-1071 [Abstract] [Full Text]  
• Gaffo, A., Saag, K. G., Curtis, J. R. (2006). Treatment of rheumatoid arthritis. Am J Health Syst Pharm 63: 2451-2465 [Abstract] [Full Text]  
• Honore, P., Donnelly-Roberts, D., Namovic, M. T., Hsieh, G., Zhu, C. Z., Mikusa, J. P., Hernandez, G., Zhong, C., Gauvin, D. M., Chandran, P., Harris, R., Medrano, A. P., Carroll, W., Marsh, K., Sullivan, J. P., Faltynek, C. R., Jarvis, M. F. (2006). A-740003 [N-(1-{[(Cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a Novel and Selective P2X7 Receptor Antagonist, Dose-Dependently Reduces Neuropathic Pain in the Rat. J. Pharmacol. Exp. Ther. 319: 1376-1385 [Abstract] [Full Text]  
• O'Sullivan, B. J., Thomas, H. E., Pai, S., Santamaria, P., Iwakura, Y., Steptoe, R. J., Kay, T. W. H., Thomas, R. (2006). IL-1beta Breaks Tolerance through Expansion of CD25+ Effector T Cells.. J. Immunol. 176: 7278-7287 [Abstract] [Full Text]  
• Ishida, Y., Kondo, T., Kimura, A., Matsushima, K., Mukaida, N. (2006). Absence of IL-1 Receptor Antagonist Impaired Wound Healing along with Aberrant NF-{kappa}B Activation and a Reciprocal Suppression of TGF-beta Signal Pathway. J. Immunol. 176: 5598-5606 [Abstract] [Full Text]  
• Cho, M.-L., Kang, J.-W., Moon, Y.-M., Nam, H.-J., Jhun, J.-Y., Heo, S.-B., Jin, H.-T., Min, S.-Y., Ju, J.-H., Park, K.-S., Cho, Y.-G., Yoon, C.-H., Park, S.-H., Sung, Y.-C., Kim, H.-Y. (2006). STAT3 and NF-{kappa}B Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice. J. Immunol. 176: 5652-5661 [Abstract] [Full Text]  
• Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., Di Virgilio, F. (2006). The P2X7 Receptor: A Key Player in IL-1 Processing and Release. J. Immunol. 176: 3877-3883 [Abstract] [Full Text]  
• Joosten, L. A. B., Netea, M. G., Kim, S.-H., Yoon, D.-Y., Oppers-Walgreen, B., Radstake, T. R. D., Barrera, P., van de Loo, F. A. J., Dinarello, C. A., van den Berg, W. B. (2006). IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 103: 3298-3303 [Abstract] [Full Text]  
• Duff, G. W (2006). Evidence for genetic variation as a factor in maintaining health. Am. J. Clin. Nutr. 83: 431S-435S [Abstract] [Full Text]  
• Matsuki, T., Nakae, S., Sudo, K., Horai, R., Iwakura, Y. (2006). Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. Int Immunol 18: 399-407 [Abstract] [Full Text]  
• Matsuzaki, T., Nakajima, A., Ishigami, S., Tanno, M., Yoshino, S. (2006). Mirthful laughter differentially affects serum pro- and anti-inflammatory cytokine levels depending on the level of disease activity in patients with rheumatoid arthritis. Rheumatology (Oxford) 45: 182-186 [Abstract] [Full Text]  
• Ohmura, K., Johnsen, A., Ortiz-Lopez, A., Desany, P., Roy, M., Besse, W., Rogus, J., Bogue, M., Puech, A., Lathrop, M., Mathis, D., Benoist, C. (2005). Variation in IL-1{beta} gene expression is a major determinant of genetic differences in arthritis aggressivity in mice. Proc. Natl. Acad. Sci. USA 102: 12489-12494 [Abstract] [Full Text]  
• Matsuki, T., Isoda, K., Horai, R., Nakajima, A., Aizawa, Y., Suzuki, K., Ohsuzu, F., Iwakura, Y. (2005). Involvement of Tumor Necrosis Factor-{alpha} in the Development of T Cell-Dependent Aortitis in Interleukin-1 Receptor Antagonist-Deficient Mice. Circulation 112: 1323-1331 [Abstract] [Full Text]  
• Shepherd, J., Nicklin, M. J.H. (2005). Elastic-Vessel Arteritis in Interleukin-1 Receptor Antagonist-Deficient Mice Involves Effector Th1 Cells and Requires Interleukin-1 Receptor. Circulation 111: 3135-3140 [Abstract] [Full Text]  
• ZWERINA, J., REDLICH, K., SCHETT, G., SMOLEN, J. S. (2005). Pathogenesis of Rheumatoid Arthritis: Targeting Cytokines. Ann. N. Y. Acad. Sci. 1051: 716-729 [Abstract] [Full Text]  
• Merhi-Soussi, F., Kwak, B. R., Magne, D., Chadjichristos, C., Berti, M., Pelli, G., James, R. W., Mach, F., Gabay, C. (2005). Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice. Cardiovasc Res 66: 583-593 [Abstract] [Full Text]  
• Schmitz, N., Kurrer, M., Bachmann, M. F., Kopf, M. (2005). Interleukin-1 Is Responsible for Acute Lung Immunopathology but Increases Survival of Respiratory Influenza Virus Infection. J. Virol. 79: 6441-6448 [Abstract] [Full Text]  
• Pascual, V., Allantaz, F., Arce, E., Punaro, M., Banchereau, J. (2005). Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J. Exp. Med. 201: 1479-1486 [Abstract] [Full Text]  
• Ashare, A., Powers, L. S., Butler, N. S., Doerschug, K. C., Monick, M. M., Hunninghake, G. W. (2005). Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L633-L640 [Abstract] [Full Text]  
• Iizasa, H., Yoneyama, H., Mukaida, N., Katakoka, Y., Naito, M., Yoshida, N., Nakashima, E., Matsushima, K. (2005). Exacerbation of Granuloma Formation in IL-1 Receptor Antagonist-Deficient Mice with Impaired Dendritic Cell Maturation Associated with Th2 Cytokine Production. J. Immunol. 174: 3273-3280 [Abstract] [Full Text]  
• Smolen, J S, Steiner, G, Aringer, M (2005). Anti-cytokine therapy in systemic lupus erythematosus. Lupus 14: 189-191 [Abstract]  
• Amcheslavsky, A., Zou, W., Bar-Shavit, Z. (2004). Toll-like Receptor 9 Regulates Tumor Necrosis Factor-{alpha} Expression by Different Mechanisms: IMPLICATIONS FOR OSTEOCLASTOGENESIS. J. Biol. Chem. 279: 54039-54045 [Abstract] [Full Text]  
• Devitt, A., Parker, K. G., Ogden, C. A., Oldreive, C., Clay, M. F., Melville, L. A., Bellamy, C. O., Lacy-Hulbert, A., Gangloff, S. C., Goyert, S. M., Gregory, C. D. (2004). Persistence of apoptotic cells without autoimmune disease or inflammation in CD14-/- mice. J. Cell Biol. 167: 1161-1170 [Abstract] [Full Text]  
• Ruddy, M. J., Shen, F., Smith, J. B., Sharma, A., Gaffen, S. L. (2004). Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J. Leukoc. Biol. 76: 135-144 [Abstract] [Full Text]  
• Wickremasinghe, M. I., Thomas, L. H., O'Kane, C. M., Uddin, J., Friedland, J. S. (2004). Transcriptional Mechanisms Regulating Alveolar Epithelial Cell-specific CCL5 Secretion in Pulmonary Tuberculosis. J. Biol. Chem. 279: 27199-27210 [Abstract] [Full Text]  
• Olsen, N. J., Stein, C. M. (2004). New Drugs for Rheumatoid Arthritis. NEJM 350: 2167-2179 [Full Text]  
• Loher, F., Bauer, C., Landauer, N., Schmall, K., Siegmund, B., Lehr, H. A., Dauer, M., Schoenharting, M., Endres, S., Eigler, A. (2004). The Interleukin-1{beta}-Converting Enzyme Inhibitor Pralnacasan Reduces Dextran Sulfate Sodium-Induced Murine Colitis and T Helper 1 T-Cell Activation. J. Pharmacol. Exp. Ther. 308: 583-590 [Abstract] [Full Text]  
• Fantuzzi, G., Banda, N. K., Guthridge, C., Vondracek, A., Kim, S.-H., Siegmund, B., Azam, T., Sennello, J. A., Dinarello, C. A., Arend, W. P. (2003). Generation and characterization of mice transgenic for human IL-18-binding protein isoform a. J. Leukoc. Biol. 74: 889-896 [Abstract] [Full Text]  
• Matsuki, T., Horai, R., Sudo, K., Iwakura, Y. (2003). IL-1 Plays an Important Role in Lipid Metabolism by Regulating Insulin Levels under Physiological Conditions. J. Exp. Med. 198: 877-888 [Abstract] [Full Text]  
• Isoda, K., Shiigai, M., Ishigami, N., Matsuki, T., Horai, R., Nishikawa, K., Kusuhara, M., Nishida, Y., Iwakura, Y., Ohsuzu, F. (2003). Deficiency of Interleukin-1 Receptor Antagonist Promotes Neointimal Formation After Injury. Circulation 108: 516-518 [Abstract] [Full Text]  
• von Stebut, E., Ehrchen, J. M., Belkaid, Y., Kostka, S. L., Molle, K., Knop, J., Sunderkotter, C., Udey, M. C. (2003). Interleukin 1{alpha} Promotes Th1 Differentiation and Inhibits Disease Progression in Leishmania major-susceptible BALB/c Mice. J. Exp. Med. 198: 191-199 [Abstract] [Full Text]  
• Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S., Iwakura, Y. (2003). IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 100: 5986-5990 [Abstract] [Full Text]  
• Juge-Aubry, C. E., Somm, E., Giusti, V., Pernin, A., Chicheportiche, R., Verdumo, C., Rohner-Jeanrenaud, F., Burger, D., Dayer, J.-M., Meier, C. A. (2003). Adipose Tissue Is a Major Source of Interleukin-1 Receptor Antagonist: Upregulation in Obesity and Inflammation. Diabetes 52: 1104-1110 [Abstract] [Full Text]  
• Gerli, R., Lunardi, C., Pitzalis, C. (2002). Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis. Rheumatology (Oxford) 41: 1341-1345 [Full Text]  
• Hallegua, D S, Weisman, M H (2002). Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis 61: 960-967 [Abstract] [Full Text]  
• Atsumi, T., Ishihara, K., Kamimura, D., Ikushima, H., Ohtani, T., Hirota, S., Kobayashi, H., Park, S.-J., Saeki, Y., Kitamura, Y., Hirano, T. (2002). A Point Mutation of Tyr-759 in Interleukin 6 Family Cytokine Receptor Subunit gp130 Causes Autoimmune Arthritis. J. Exp. Med. 196: 979-990 [Abstract] [Full Text]  
• Abramson, S. B., Amin, A. (2002). Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology (Oxford) 41: 972-980 [Abstract] [Full Text]  
• Irikura, V. M., Lagraoui, M., Hirsh, D. (2002). The Epistatic Interrelationships of IL-1, IL-1 Receptor Antagonist, and the Type I IL-1 Receptor. J. Immunol. 169: 393-398 [Abstract] [Full Text]  
• Graudal, N A, Svenson, M, Tarp, U, Garred, P, Jurik, A-G, Bendtzen, K (2002). Autoantibodies against interleukin 1{alpha} in rheumatoid arthritis: association with long term radiographic outcome. Ann Rheum Dis 61: 598-602 [Abstract] [Full Text]  
• Lewis, D. B. (2002). Simple Febrile Seizures: Do Polymorphisms of the Interleukin 1 Gene Cluster Simplify Our Understanding?. Arch Pediatr Adolesc Med 156: 529-530 [Full Text]  
• Hultgren, O. H., Svensson, L., Tarkowski, A. (2002). Critical Role of Signaling Through IL-1 Receptor for Development of Arthritis and Sepsis During Staphylococcus aureus Infection. J. Immunol. 168: 5207-5212 [Abstract] [Full Text]  
• Devlin, C. M., Kuriakose, G., Hirsch, E., Tabas, I. (2002). Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size. Proc. Natl. Acad. Sci. USA 99: 6280-6285 [Abstract] [Full Text]  
• Werner, E., Kheradmand, F., Isberg, R. R., Werb, Z. (2002). Phagocytosis mediated by Yersinia invasin induces collagenase-1 expression in rabbit synovial fibroblasts through a proinflammatory cascade. J. Cell Sci. 114: 3333-3343 [Abstract] [Full Text]  
• Meier, C. A., Bobbioni, E., Gabay, C., Assimacopoulos-Jeannet, F., Golay, A., Dayer, J.-M. (2002). IL-1 Receptor Antagonist Serum Levels Are Increased in Human Obesity: A Possible Link to the Resistance to Leptin?. J. Clin. Endocrinol. Metab. 87: 1184-1188 [Abstract] [Full Text]  
• Attur, M. G., Dave, M. N., Leung, M. Y., Cipolletta, C., Meseck, M., Woo, S. L. C., Amin, A. R. (2002). Functional Genomic Analysis of Type II IL-1{beta} Decoy Receptor: Potential for Gene Therapy in Human Arthritis and Inflammation. J. Immunol. 168: 2001-2010 [Abstract] [Full Text]  
• Siegmund, B., Lehr, H.-A., Fantuzzi, G., Dinarello, C. A. (2001). IL-1beta -converting enzyme (caspase-1) in intestinal inflammation. Proc. Natl. Acad. Sci. USA 10.1073/pnas.231473998v1 [Abstract] [Full Text]  
• Davidson, A., Diamond, B. (2001). Autoimmune Diseases. NEJM 345: 340-350 [Full Text]  
• Wipke, B. T., Allen, P. M. (2001). Essential Role of Neutrophils in the Initiation and Progression of a Murine Model of Rheumatoid Arthritis. J. Immunol. 167: 1601-1608 [Abstract] [Full Text]  
• Nakae, S., Asano, M., Horai, R., Sakaguchi, N., Iwakura, Y. (2001). IL-1 Enhances T Cell-Dependent Antibody Production Through Induction of CD40 Ligand and OX40 on T Cells. J. Immunol. 167: 90-97 [Abstract] [Full Text]  
• Gabay, C., Dreyer, M. G., Pellegrinelli, N., Chicheportiche, R., Meier, C. A. (2001). Leptin Directly Induces the Secretion of Interleukin 1 Receptor Antagonist in Human Monocytes. J. Clin. Endocrinol. Metab. 86: 783-791 [Abstract] [Full Text]  
• Arend, W. P, Guthridge, C. J (2000). Biological role of interleukin 1 receptor antagonist isoforms. Ann Rheum Dis 59: i60-64 [Abstract] [Full Text]  
• van den Berg, W. B (2000). Arguments for interleukin 1 as a target in chronic arthritis. Ann Rheum Dis 59: i81-84 [Abstract] [Full Text]  
• Dinarello, C. A. (2000). The Role of the Interleukin-1-Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1. NEJM 343: 732-734 [Full Text]  
• Attur, M. G., Dave, M., Cipolletta, C., Kang, P., Goldring, M. B., Patel, I. R., Abramson, S. B., Amin, A. R. (2000). Reversal of Autocrine and Paracrine Effects of Interleukin 1 (IL-1) in Human Arthritis by Type II IL-1 Decoy Receptor. POTENTIAL FOR PHARMACOLOGICAL INTERVENTION. J. Biol. Chem. 275: 40307-40315 [Abstract] [Full Text]  
• Vigers, G. P. A., Dripps, D. J., Edwards, C. K. III, Brandhuber, B. J. (2000). X-ray Crystal Structure of a Small Antagonist Peptide Bound to Interleukin-1 Receptor Type 1. J. Biol. Chem. 275: 36927-36933 [Abstract] [Full Text]  
• Siegmund, B., Lehr, H.-A., Fantuzzi, G., Dinarello, C. A. (2001). IL-1beta -converting enzyme (caspase-1) in intestinal inflammation. Proc. Natl. Acad. Sci. USA 98: 13249-13254 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS